Boston Therapeutics launches blood sugar management supplement
Boston Therapeutics (BTI) has entered the full commercialization phase of its Sugardown dietary supplement aimed at the healthy blood sugar management market. The company is collaborating on the launch with Benchworks, a Maryland-based marketing firm.